Healthcare provider profile · identity verified

Dawn R Hostetler, MD

Family Practice · BROWNSBURG, IN · NPI 1902846793

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	563	169
Levothyroxine Sodium	Levothyroxine Sodium	380	100
Amlodipine Besylate	Amlodipine Besylate	341	102
Lisinopril	Lisinopril	314	91
Omeprazole	Omeprazole	288	89
Metoprolol Succinate	Metoprolol Succinate	246	73
Losartan Potassium	Losartan Potassium	201	58
Rosuvastatin Calcium	Rosuvastatin Calcium	145	49
Gabapentin	Gabapentin	139	42
Metoprolol Tartrate	Metoprolol Tartrate	128	39
Ezetimibe	Ezetimibe	114	31
Simvastatin	Simvastatin	113	32
Duloxetine Hcl	Duloxetine Hcl	110	33
Pantoprazole Sodium	Pantoprazole Sodium	109	34
Metformin Hcl	Metformin Hcl	108	33
Furosemide	Furosemide	97	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	93	30
Metformin Hcl Er	Metformin Hcl	91	31
Prednisone	Prednisone	90	87
Sertraline Hcl	Sertraline Hcl	87	22
Famotidine	Famotidine	86	34
Baclofen	Baclofen	84	36
Albuterol Sulfate Hfa	Albuterol Sulfate	79	33
Fluoxetine Hcl	Fluoxetine Hcl	79	23
Hydrochlorothiazide	Hydrochlorothiazide	76	25
Meloxicam	Meloxicam	76	24
Escitalopram Oxalate	Escitalopram Oxalate	70	19
Zolpidem Tartrate	Zolpidem Tartrate	68	21
Celecoxib	Celecoxib	63	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	18
Glipizide	Glipizide	60	15
Mounjaro	Tirzepatide	58	suppressed
Pravastatin Sodium	Pravastatin Sodium	55	17
Allopurinol	Allopurinol	54	13
Chlorthalidone	Chlorthalidone	50	16
Trazodone Hcl	Trazodone Hcl	48	18
Potassium Chloride	Potassium Chloride	46	15
Tamsulosin Hcl	Tamsulosin Hcl	46	12
Spironolactone	Spironolactone	44	14
Oxybutynin Chloride	Oxybutynin Chloride	43	14
Carvedilol	Carvedilol	40	12
Montelukast Sodium	Montelukast Sodium	40	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	suppressed
Tramadol Hcl	Tramadol Hcl	39	suppressed
Glipizide Er	Glipizide	38	11
Bupropion Xl	Bupropion Hcl	37	11
Sumatriptan Succinate	Sumatriptan Succinate	37	suppressed
Synthroid	Levothyroxine Sodium	37	suppressed
Alendronate Sodium	Alendronate Sodium	36	suppressed
Azithromycin	Azithromycin	35	34
Fluticasone Propionate	Fluticasone Propionate	33	17
Atenolol	Atenolol	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Eliquis	Apixaban	31	suppressed
Mirtazapine	Mirtazapine	31	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Acyclovir	Acyclovir	28	11
Doxycycline Monohydrate	Doxycycline Monohydrate	27	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Trulicity	Dulaglutide	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Jardiance	Empagliflozin	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	22
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	13
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Ozempic	Semaglutide	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	13
Donepezil Hcl	Donepezil Hcl	18	suppressed
Primidone	Primidone	18	suppressed
Cephalexin	Cephalexin	17	17
Klor-Con M20	Potassium Chloride	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Ramipril	Ramipril	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	14
Amoxicillin	Amoxicillin	16	16
Buspirone Hcl	Buspirone Hcl	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Clonazepam	Clonazepam	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Fluconazole	Fluconazole	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Torsemide	Torsemide	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Farxiga	Dapagliflozin Propanediol	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error